임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
41건 표시
- 2상모집 중· Non-small Cell Lung Cancer Stage IIINeoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement
협력: 리제네론
- 2상모집 중· Colon and Rectal CancerGemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
협력: 리제네론
- 2상모집 중· HypercholesterolemiaA Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
리드: 리제네론
- 2상모집 중· Merkel Cell Carcinoma, Stage INeoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
협력: 리제네론
- 2상모집 중· Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
리드: 리제네론
- 2상모집 중· Pancreatic Ductal Adenocarcinoma (mPDAC)Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
협력: 리제네론
- 2상모집 중· Pulmonary Arterial Hypertension (PAH)Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
리드: 리제네론
- 2상모집 중· Advanced Renal Cell Carcinoma (aRCC)A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
협력: 리제네론
- 2상모집 중· Head and Neck Squamous Cell Carcinoma (HNSCC)A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
리드: 리제네론
- 2상모집 중· Advanced/Metastatic Non-Small Cell Lung CancerA Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
리드: 리제네론
- 2상모집 중· Functional Hypothalamic Amenorrhea (FHA)A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
리드: 리제네론
- 2상모집 중· Clear Cell Renal Cell CarcinomaCemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
협력: 리제네론
- 2상모집 중· Diabetic Kidney Disease (DKD)Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
리드: 리제네론
- 2상모집 중· NSCLC (Advanced Non-small Cell Lung Cancer)Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
협력: 리제네론
- 2상모집 중· Atrial Fibrillation (AF)Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
리드: 리제네론
- 2상모집 중· Recurrent Diffuse Large B-Cell LymphomaOdronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
협력: 리제네론
- 2상모집 중· Basal Cell Carcinoma (BCC)Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
협력: 리제네론
- 2상모집 중· Solid TumorsPhase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
협력: 리제네론, 사노피
- 2상모집 중· Melanoma BRAF V600E/K MutatedEncorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases
협력: 리제네론
- 2상모집 중· Carcinoma, Non-Small-Cell LungPreoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
협력: 리제네론
- 2상모집 중· PruritisDupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
협력: 리제네론
- 2상모집 중· Locally Recurrent Oral Cavity Squamous Cell CarcinomaCemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
협력: 리제네론
- 2상모집 중· Metastatic Uveal MelanomaStudy of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
협력: 리제네론, 사노피
- 2상모집 중· SMARCB1-Deficient MalignanciesPhase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
협력: 리제네론
- 2상모집 중· Monoclonal Gammopathy of Undetermined Significance (MGUS)A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
리드: 리제네론
- 2상모집 중· Advanced MelanomaA Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
협력: 리제네론
- 2상모집 중· Colorectal CancerCemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
협력: 리제네론
- 2상모집 중· Metabolic Dysfunction-Associated SteatoHepatitis (MASH)A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
리드: 리제네론
- 2상모집 중· HPV-Related Squamous Cell CarcinomaTrial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
협력: 리제네론
- 2상모집 중· Pancreatic CancerChemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
협력: 리제네론
- 2상모집 중· Juvenile Idiopathic ArthritisA Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
리드: 사노피 · 협력: 리제네론
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.